Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
hLEC |
Human lens epithelial cell line | Human | sensory organs | cell line | adherent | plasmid | stable transfection | Metafectene PRO | publication | Y. Su et al., Molecular Vision, 2012, 18: 601-605 | Link | ||
hLEC |
Human lens epithelial cell line | Human | sensory organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | Y. Su et al., Molecular Vision, 2012, 18: 601-605 | Link | ||
HL-60 |
Human adult acute myeloid leukemia cell line | ATCC CCL-240 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | B. Landry et al., PLoS ONE, 2012, 7(8): e44197, doi:10.1371/journal.pone.0044197 | Link | |
HK-2 |
Human kidney cell line HPV-16 transformed | ATCC CRL-2190 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | E. Alcaraz et al., PLoS ONE, 2019, 15(1): e0227340, doi.org/10.1371/journal.pone.0227340 | Link | ||
HK-2 |
Human kidney cell line HPV-16 transformed | ATCC CRL-2190 | Human | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | E. Alcaraz, Dissertation, 2015, University of Barcelona | ||
HK-2 |
Human kidney cell line HPV-16 transformed | ATCC CRL-2190 | Human | urinary system | cell line | adherent | plasmid | Metafectene PRO | publication | E. Alcaraz, Dissertation, 2015, University of Barcelona | |||
HIT-T15 |
Hamster pancreas beta cell line | ATCC CRL-1777 | Hamster | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | J. E. D. Escobar, Universität Hamburg | Link | ||
hESC-RPE |
Human embryonic stem cell-derived retinal pigment epithelium cells | Human | sensory organs | primary cell | siRNA | RNA-Interference | Metafectene PRO | publication | E. Ramsay et al., Pharmaceutics, 2020, 12(7): 667, doi: 10.3390/pharmaceutics12070667 | Link | |||
hESC |
Human embryonic stem cells | Human | unknown | stem cell | adherent | plasmid | Metafectene PRO | publication | J. Suchánková et al., Europ. J. of Histochemistry, 2014; 58:2389, doi:10.4081/ejh.2014.2389 | Link | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | L. Siculella et al., Int. J. Mol. Sci., 2020, 21: 1206, doi:10.3390/ijms21041206 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | miRNA | Metafectene PRO | publication | D.-W. Choi et al., Int. J. Mol. Med., 2021,48(6): 221, DOI: 10.3892/ijmm.2021.5054 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Wedeken et al., J. Biol. Chem., Dec 2011; 286: 42855 - 42862. | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | application note | ![]() |
|||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | F. Damiano et al., Bbamcb, 2018, doi.org/10.1016/j.bbalip.2018.01.006 | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | C. Maucksch et al., Nucleic Acids Res., Oct 2008; 36: 5462 - 5471 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. I. Koukourakis et al., Investigational New Drugs, 2018, doi.org/10.1007/s10637-018-0566-0 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | C. Ullio et al., J. Lipid Res., Jun 2012; 53: 1134 - 1143 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | miRNA | Metafectene PRO | publication | M. Vinod et al., Biochim. et Biophys. Acta, 2014, 1841: 827-835, doi.org/10.1016/j.bbalip.2014.02.006 | Link | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | F. Damiano et al., Biochem. J., 2013, 449: 543–553, doi:10.1042/BJ20120906 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | cotransfection (plasmid/siRNA) | Metafectene PRO | publication | F. Damiano et al., Biochem. J., 2013, 449: 543–553, doi:10.1042/BJ20120906 | ||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | O. Pellerito et al., Mol. Pharmacol., May 2010; 77: 854 - 863 | Link | |
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | Metafectene PRO | publication | L. Siculella et al., Biochim. et Biophys. Acta, 2016, 1861: 471-481; doi.org/10.1016/j.bbalip.2016.02.003 | |||
HepG2 |
Human hepatocellular carcinoma cell line | ATCC HB-8065 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | M.I. Koukourakis et al., Scientific Reports, 2016, 6:30986; DOI: 10.1038/srep30986 | Link | |
hEPC |
Human endothelial progenitor cells | Human | other | primary cell | adherent | plasmid | Metafectene PRO | publication | G. Neumann, Dissertation, 2015, Georg-August-Universität zu Göttingen | Link |